Raisi-Estabragh, Zahra
Martineau, Adrian R.
Curtis, Elizabeth M.
Moon, Rebecca J.
Darling, Andrea
Lanham-New, Susan
Ward, Kate A.
Cooper, Cyrus
Munroe, Patricia B.
Petersen, Steffen E.
Harvey, Nicholas C. http://orcid.org/0000-0002-8194-2512
Article History
Received: 2 April 2021
Accepted: 23 May 2021
First Online: 12 June 2021
Declarations
:
: NCH reports personal fees, consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, UCB, Consilient Healthcare, Kyowa Kirin and Internis Pharma, outside the submitted work. ZRE reports no conflicts of interest. ARM reports grant support for the CORONAVIT trial from Pharma Nord Ltd, Synergy Biologics Ltd, Cytoplan Ltd, and DSM Ltd, outside the submitted work. RJM has no disclosures. EMC reports conference support and lecture fees from Eli Lilly, UCB and Amgen, outside the submitted work. KAW reports lecture fees from Abbott Nutrition and Pfizer Healthcare, outside the submitted work. ALD was an expert advisor on the NICE Vitamin D and COVID-19 evidence review (2020). SLN is a member of SACN Main Committee and was on the SACN Vitamin D working group responsible for setting the new vitamin D recommendations for the UK (2010–2016); contributing to the SACN ARTI Report and the NICE Vitamin D and COVID-19 Report. SLN also declares reports honorariums received from Thornton Ross and the US Council for Responsible Nutrition on vitamin D, both of which have been donated to charities. CC, PBM, and SEP declare that they have no conflict of interest.
: Ethics review and informed consent are not applicable.
: There was no direct involvement of patients or participants in this literature review.